NEW YORK (GenomeWeb) – Molecular diagnostics manufacturer Cepheid announced today preliminary fourth quarter financial results.

For the quarter ended Dec. 31, 2015, the company expects to report revenue of about $147 million, the firm noted in a statement.

This revenue was driven by "stronger than expected" performance of the company's commercial systems and high-burden developing country sales, and was offset by reduced revenue from commercial influenza due to a delayed and "possibly milder than expected" influenza season.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.